Long-term efficacy and safety of microwave ablation for hepatocellular carcinoma adjacent to the gallbladder with a diameter ≤ 5 cm: a multicenter, propensity score matching study

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Vogel A, Meyer T, Sapisochin G, et al. Hepatocellular carcinoma. Lancet. 2022;400(10360):1345–1362. doi: 10.1016/S0140-6736(22)01200-4.
   PubMed Web of Science ®Google Scholar
• Sun N, Lee YT, Zhang RY, et al. Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring. Nat Commun. 2020;11(1):4489. doi: 10.1038/s41467-020-18311-0.
   PubMed Web of Science ®Google Scholar
• Olivo R, Guarrera JV, Pyrsopoulos NT. Liver transplantation for acute liver failure. Clin Liver Dis. 2018;22(2):409–417. doi: 10.1016/j.cld.2018.01.014.
   PubMed Web of Science ®Google Scholar
• Williams R, Alexander G, Aspinall R, et al. Gathering momentum for the way ahead: fifth report of the lancet standing commission on liver disease in the UK. Lancet. 2018;392(10162):2398–2412. doi: 10.1016/S0140-6736(18)32561-3.
   PubMed Web of Science ®Google Scholar
• Yu J, Cheng ZG, Han ZY, et al. Period-dependent survival benefit of percutaneous microwave ablation for hepatocellular carcinoma: a 12-year real-world, multicentric experience. Liver Cancer. 2022;11(4):341–353. doi: 10.1159/000522134.
   PubMed Web of Science ®Google Scholar
• Wang Z, Liu M, Zhang DZ, et al. Microwave ablation versus laparoscopic resection as first-line therapy for solitary 3-5-cm HCC. Hepatology. 2022;76(1):66–77. doi: 10.1002/hep.32323.
   PubMed Web of Science ®Google Scholar
• Laimer G, Schullian P, Jaschke N, et al. Minimal ablative margin (MAM) assessment with image fusion: an independent predictor for local tumor progression in hepatocellular carcinoma after stereotactic radiofrequency ablation. Eur Radiol. 2020;30(5):2463–2472. doi: 10.1007/s00330-019-06609-7.
   PubMed Web of Science ®Google Scholar
• Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol. 2022;76(3):681–693. doi: 10.1016/j.jhep.2021.11.018.
   PubMed Web of Science ®Google Scholar
• Radosevic A, Quesada R, Serlavos C, et al. Microwave versus radiofrequency ablation for the treatment of liver malignancies: a randomized controlled phase 2 trial. Sci Rep. 2022;12(1):316. doi: 10.1038/s41598-021-03802-x.
   PubMedGoogle Scholar
• An C, Li WZ, Huang ZM, et al. Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis. Eur Radiol. 2021;31(7):4764–4773. doi: 10.1007/s00330-020-07571-5.
   PubMed Web of Science ®Google Scholar
• Yu J, Yu XL, Han ZY, et al. Percutaneous cooled-probe microwave versus radiofrequency ablation in early-stage hepatocellular carcinoma: a phase III randomised controlled trial. Gut. 2017;66(6):1172–1173. doi: 10.1136/gutjnl-2016-312629.
   PubMed Web of Science ®Google Scholar
• Huang H, Liang P, Yu XL, et al. Safety assessment and therapeutic efficacy of percutaneous microwave ablation therapy combined with percutaneous ethanol injection for hepatocellular carcinoma adjacent to the gallbladder. Int J Hyperthermia. 2015;31(1):40–47. doi: 10.3109/02656736.2014.999017.
   PubMed Web of Science ®Google Scholar
• Zhang M, Liang P, Cheng ZG, et al. Efficacy and safety of artificial ascites in assisting percutaneous microwave ablation of hepatic tumours adjacent to the gastrointestinal tract. Int J Hyperthermia. 2014;30(2):134–141. doi: 10.3109/02656736.2014.891765.
   PubMed Web of Science ®Google Scholar
• Huang S, Yu J, Liang P, et al. Percutaneous microwave ablation for hepatocellular carcinoma adjacent to large vessels: a long-term follow-up. Eur J Radiol. 2014;83(3):552–558. doi: 10.1016/j.ejrad.2013.12.015.
   PubMed Web of Science ®Google Scholar
• Hu H, Chi JC, Liu R, et al. Microwave ablation for peribiliary hepatocellular carcinoma: propensity score analyses of long-term outcomes. Int J Hyperthermia. 2021;38(1):191–201. doi: 10.1080/02656736.2019.1706766.
   PubMed Web of Science ®Google Scholar
• Meng Y, Jiang B, Yan K, et al. Evaluation of the safety and efficacy of ultrasound-guided percutaneous radiofrequency ablation for hepatocellular carcinoma and liver metastases adjacent to the gallbladder. Int J Hyperthermia. 2023;40:2182748.
   PubMed Web of Science ®Google Scholar
• Yao J, Liu B, Wang X, et al. Long-term efficacy of microwave ablation in the treatment of subcapsular hepatocellular carcinomas of ≤3 cm in diameter: a multicenter, propensity score-matched study. Int J Hyperthermia. 2022;39(1):209–216. doi: 10.1080/02656736.2021.2023228.
   PubMed Web of Science ®Google Scholar
• Mukund A, Ramalingam R, Anandpara KM, et al. Efficacy and safety of percutaneous microwave ablation for hepatocellular carcinomas <4 cm in difficult location. Br J Radiol. 2020;93(1116):20191025. doi: 10.1259/bjr.20191025.
   PubMed Web of Science ®Google Scholar
• An C, Cheng Z, Yu X, et al. Ultrasound-guided percutaneous microwave ablation of hepatocellular carcinoma in challenging locations: oncologic outcomes and advanced assistive technology. Int J Hyperthermia. 2020;37(1):89–100. doi: 10.1080/02656736.2019.1711203.
   PubMed Web of Science ®Google Scholar
• Filippiadis DK, Spiliopoulos S, Konstantos C, et al. Computed tomography-guided percutaneous microwave ablation of hepatocellular carcinoma in challenging locations: safety and efficacy of high-power microwave platforms. Int J Hyperthermia. 2018;34(6):863–869. doi: 10.1080/02656736.2017.1370728.
   PubMed Web of Science ®Google Scholar
• Li M, Yu X, Liang P, et al. Ultrasound-guided percutaneous microwave ablation for hepatic malignancy adjacent to the gallbladder. Int J Hyperthermia. 2015;31(6):579–587. doi: 10.3109/02656736.2015.1014869.
   PubMed Web of Science ®Google Scholar
• Li Y, Li X, Xiao J, et al. Ultrasound-guided microwave ablation combined with ethanol injection for the treatment of solitary nodular retrosternal goiter: a prospective study of 72 patients. Eur Radiol. 2023;33(2):752–762. doi: 10.1007/s00330-022-09052-3.
   PubMed Web of Science ®Google Scholar
• Zhang D, Liang P, Yu X, et al. The value of artificial pleural effusion for percutaneous microwave ablation of liver tumour in the hepatic dome: a retrospective case-control study. Int J Hyperthermia. 2013;29(7):663–670. doi: 10.3109/02656736.2013.833347.
   PubMed Web of Science ®Google Scholar
• Zhi-Yu H, Ping L, Xiao-Ling Y, et al. A clinical study of thermal monitoring techniques of ultrasound-guided microwave ablation for hepatocellular carcinoma in high-risk locations. Sci Rep. 2017;7:41246. doi: 10.1038/srep41246.
   PubMed Web of Science ®Google Scholar
• Francica G, Meloni MF, Riccardi L, et al. Ablation treatment of primary and secondary liver tumors under contrast-enhanced ultrasound guidance in field practice of interventional ultrasound centers. A multicenter study. Eur J Radiol. 2018;105:96–101. doi: 10.1016/j.ejrad.2018.05.030.
   PubMed Web of Science ®Google Scholar
• Ahmed M, Solbiati L, Brace CL, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria–a 10-year update. Radiology. 2014;273(1):241–260. doi: 10.1148/radiol.14132958.
   PubMed Web of Science ®Google Scholar
• Rhim H, Dodd GD, 3rd, Chintapalli KN, et al. Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics. 2004;24(1):41–52. doi: 10.1148/rg.241025144.
   PubMed Web of Science ®Google Scholar
• Xu XF, Xing H, Han J, et al. Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China. JAMA Surg. 2019;154(3):209–217. doi: 10.1001/jamasurg.2018.4334.
   PubMed Web of Science ®Google Scholar
• Heerink WJ, Solouki AM, Vliegenthart R, et al. The relationship between applied energy and ablation zone volume in patients with hepatocellular carcinoma and colorectal liver metastasis. Eur Radiol. 2018;28(8):3228–3236. doi: 10.1007/s00330-017-5266-1.
   PubMed Web of Science ®Google Scholar
• Yu J, Liang P, Yu X, et al. A comparison of microwave ablation and bipolar radiofrequency ablation both with an internally cooled probe: results in ex vivo and in vivo porcine livers. Eur J Radiol. 2011;79(1):124–130. doi: 10.1016/j.ejrad.2009.12.009.
   PubMed Web of Science ®Google Scholar
• Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–380. doi: 10.1002/hep.29086.
   PubMed Web of Science ®Google Scholar
• Vogel A, Cervantes A, Chau I, et al. Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv238–iv255. doi: 10.1093/annonc/mdy308.
   PubMed Web of Science ®Google Scholar
• Cao S, Lyu T, Fan Z, et al. Long-term outcome of percutaneous radiofrequency ablation for periportal hepatocellular carcinoma: tumor recurrence or progression, survival and clinical significance. Cancer Imaging. 2022;22(1):2. doi: 10.1186/s40644-021-00442-2.
   PubMed Web of Science ®Google Scholar
• Zhang NN, Lu W, Cheng XJ, et al. High-powered microwave ablation of larger hepatocellular carcinoma: evaluation of recurrence rate and factors related to recurrence. Clin Radiol. 2015;70(11):1237–1243. doi: 10.1016/j.crad.2015.06.092.
   PubMed Web of Science ®Google Scholar
• Chen J, Peng K, Hu D, et al. Tumor location influences oncologic outcomes of hepatocellular carcinoma patients undergoing radiofrequency ablation. Cancers (Basel). 2018;10(10):378. doi: 10.3390/cancers10100378.
   Web of Science ®Google Scholar
• Lee J, Rhim H, Jeon YH, et al. Radiofrequency ablation of liver adjacent to body of gallbladder: histopathologic changes of gallbladder wall in a pig model. AJR Am J Roentgenol. 2008;190(2):418–425. doi: 10.2214/AJR.07.2526.
   PubMed Web of Science ®Google Scholar
• Fukuda K, Mori K, Hasegawa N, et al. Safety margin of radiofrequency ablation for hepatocellular carcinoma: a prospective study using magnetic resonance imaging with superparamagnetic iron oxide. Jpn J Radiol. 2019;37(7):555–563. doi: 10.1007/s11604-019-00843-1.
   PubMed Web of Science ®Google Scholar
• Kobe A, Kindler Y, Klotz E, et al. Fusion of preinterventional MR imaging with liver perfusion CT after RFA of hepatocellular carcinoma: early quantitative prediction of local recurrence. Invest Radiol. 2021;56(3):188–196. doi: 10.1097/RLI.0000000000000726.
   PubMed Web of Science ®Google Scholar
• Li FY, Li JG, Wu SS, et al. An optimal ablative margin of small single hepatocellular carcinoma treated with Image-Guided percutaneous thermal ablation and local recurrence prediction base on the ablative margin: a multicenter study. J Hepatocell Carcinoma. 2021;8:1375–1388. doi: 10.2147/JHC.S330746.
   PubMed Web of Science ®Google Scholar
• Liu C, He J, Li T, et al. Evaluation of the efficacy and postoperative outcomes of hydrodissection-assisted microwave ablation for subcapsular hepatocellular carcinoma and colorectal liver metastases. Abdom Radiol (NY). 2021;46(5):2161–2172. doi: 10.1007/s00261-020-02830-x.
   PubMed Web of Science ®Google Scholar
• Kim SW, Rhim H, Park M, et al. Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: assessment of safety and therapeutic efficacy. Korean J Radiol. 2009;10(4):366–376. doi: 10.3348/kjr.2009.10.4.366.
   PubMed Web of Science ®Google Scholar
• Facciorusso A, Del Prete V, Crucinio N, et al. Angiotensin receptor blockers improve survival outcomes after radiofrequency ablation in hepatocarcinoma patients. J Gastroenterol Hepatol. 2015;30(11):1643–1650. doi: 10.1111/jgh.12988.
   PubMed Web of Science ®Google Scholar